In vitro generation of cytotoxic lymphocytes against radiation and radiation leukemia virus-induced tumors - I. Role of viral antigenicity

Cancer Immunology Immunotherapy

Volumn 8, Issue 2-3, 1980, Pages 171-178

  Yefenof, E ^a   Tchakirov, Rachel ^a   Kedar, E ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD AND HEMOPOIETIC SYSTEM; CYTOTOXICITY; LEUKEMIA; LYMPHATIC SYSTEM; LYMPHOCYTE; RADIATION LEUKEMIA VIRUS;

EID: 0018889507     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/BF00205669     Document Type: Article

References (54)

1. Surface antigens on transplantable tumor cell-lines producing mouse type C viruses
2. Immunological aspects of chemical carcinogenesis
3. Host response against oncorna virus-induced lymphomas in mice
4. T lymphocyte response to Freind virus-induced tumor cell-lines in mice of strains congenic at H-2
5. Progressive loss of H-2 antigens with concomitant increase of cell surface antigen(s) determined by leukaemia virus in cultured murine lymphomas
6. Selective thymic localization of murine leukemia virus related antigens in C5713L/Ka mice after inoculation with radiation leukemia virus
7. Focal infection and transformation in situ of thymus cell subclasses by a thymotropic murine leukemia virus
8. Specificity of virus-immune effect of T cells for H-2K or H-2D compatible interactions. Implications for H-antigen diversity
9. Immunization of mice with syngeneic Moloney lymphoma cells induces separate antibodies against virion envelope glycoprotein and virus induced cell surface antigens
10. H-2 antigen expression: Loss in vitro, restoration in vivo, and correlation with cell-mediated cytotoxicity in a mouse lymphoma cell-line
11. Overcoming low responsiveness by priming mice with a syngeneic in vitro tumor line or allogeneic cross-reactive tumor
12. Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas
13. Studies on the nature of the cell surface antigen reacting with cytolytic T lymphocytes in murine oncornavirus induced tumors
14. Studies in antibody response of mice to tumor inoculation
15. Continuous production of radiation leukemia virus in C57BL thymoma tissue culture lines: Purification of the leukemogenic virus
16. Transient virus expression during murine leukemia inducation by X-irradiation
17. Host virus relationship in radiation leukemogenesis
18. Spontaneous and induced preleukemia cells in C57BL mice
19. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants
20. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumors of spontaneous origin
21. Radiation leukemia in C57BL mice. II. Lack of ecotropic virus expression in the majority of lymphomas
22. On the natural history of the murine leukemias
23. Amplification of the generation of cytotoxic lymphocytes by enzymatically and chemically modified stimulator leukemic cells
24. Optimization of tissue culture conditions for the generation of cytotoxic lymphocytes
25. Cytotoxic activity in vitro and tumor neutralizing capacity in vivo of anti-leukemia cytotoxic lymphocytes generated in macrocultures
26. Effect of methanol extraction residue fraction of BCG on the generation of cytotoxic lymphocytes against leukemia
27. Adoptive immunotherapy in combination with chemotherapy of leukemia in mice, using lymphocytes sensitized in vitro to leukemia cells
28. Adoptive immunotherapy of leukemia in mice with lymphocytes sensitized in vitro to leukemia cells
29. Immunological surveillance against neoplasia
30. Antigenic properties of lymphomas induced by the Moloney agent
31. Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: Contrasting consequences of host versus tumor evolution
32. Modification in growth of transplantable rat tumors exposed to Friend virus
33. Molecular association between transplantation antigens and cell surface antigens in adenovirus transformed cell-lines
34. The murine sarcoma virus induced tumor: Exception or general model in tumor immunology?
35. Stropic murine type-C viruses: Frequency of isolation from continuous cell-lines, leukemia virus preparations and normal spleens
36. Leukemogenic activity of filtrates from radiation induced lymphoid tumors of mice
37. Anomalous viral expression in radiogenic lymphomas of C57BL/6/Ku mice
38. Comparative studies on the induction of transplantation resistance in BALB/c and C57BL/6 mice in three murine leukemia systems
39. Immunological approaches of leukemia treatment
40. Horizons in tumor immunology
41. The clonal evolution of tumor cell populations
42. Alteration of cell surface antigenicity of the mouse plasmacytoma. I. Immunologic characterization of surface antigens masked during successive transplantation
43. Immunosuppression by the radiation leukemia virus and its relation to lymphatic leukemia development
44. Prospects for the immunotherapy of cancer
45. Studies on the specificity and control of the cytolytic T lymphocyte response to murine leukemia virus induced tumors
46. Tumor progression and homeostasis
47. Passive immunotherapy of cancer in animals and man
48. Experimental models of tumor immunotherapy
49. The specificity of effector T cells activated by tumors induced by murine oncornaviruses
50. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer
51. Cell-mediated cytotoxicity to SV40 specific tumor associated antigens
52. The questionable immunogenicity of certain neoplasms
53. Antibody-induced redistribution of normal and tumor associated surface antigens
54. Association of mouse major histocompatibility and Rauscher murine leukemia virus envelope glycoprotein antigens on leukemia cells and their recognition by syngeneic virus immune cytotoxic T lymphocytes